Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases
暂无分享,去创建一个
[1] S. Corsello,et al. Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine , 2004, European Journal of Nuclear Medicine.
[2] A. Novick,et al. Successful outcomes in pheochromocytoma surgery in the modern era. , 1999, The Journal of urology.
[3] P. Choyke,et al. Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. , 1999, The Journal of urology.
[4] M. Walther,et al. Pheochromocytoma: evaluation, diagnosis, and treatment , 1999, World Journal of Urology.
[5] Y. Okuda,et al. Three Cases of Malignant Pheochromocytoma Treated withCyc lophosphamide, Vincristine, and Dacarbazine Combination Chemotherapy and Alpha-Methyl- p-Tyrosine to Control Hypercatecholaminemia , 1998, Hormone Research in Paediatrics.
[6] J. Ortuño,et al. Malignant pheochromocytoma, still a therapeutic challenge. , 1997, American Journal of Hypertension.
[7] K. Nakao,et al. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin , 1996, Journal of Molecular Medicine.
[8] B. Pasini,et al. Malignant Pheochromocytoma in Multiple Endocrine Neoplasia Type 2B Syndrome. Case Report and Review of the Literature , 1996, Tumori.
[9] M. Ito,et al. A case of von Recklinghausen's disease with bilateral pheochromocytoma-malignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors. , 1996, The American journal of surgical pathology.
[10] P. Dicpinigaitis,et al. Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine. , 1994, Medical and pediatric oncology.
[11] A. Weaver,et al. Pheochromocytoma--continuing evolution of surgical therapy. , 1993, Surgery.
[12] M. Brennan,et al. Comparison of adrenal and extraadrenal pheochromocytomas. , 1993, Surgery.
[13] K. Tsao,et al. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas. , 1993, Archives of pathology & laboratory medicine.
[14] M. Schlumberger,et al. Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases , 1992, Journal of endocrinological investigation.
[15] C. Badet,et al. Malignant pheochromocytoma: A series of 14 cases observed between 1966 and 1990 , 1992, Journal of endocrinological investigation.
[16] J. O'fallon,et al. The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma , 1992, Cancer.
[17] C. Schvartz,et al. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma. , 1991, Journal of nuclear biology and medicine.
[18] M. Krempf,et al. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study. , 1991, Journal of nuclear biology and medicine.
[19] M. D. De Santis,et al. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group. , 1991, Journal of nuclear biology and medicine.
[20] J. Schornagel,et al. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication. , 1991, Journal of nuclear biology and medicine.
[21] K. Zasadny,et al. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. , 1991, Journal of nuclear biology and medicine.
[22] P. Unger,et al. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. , 1991, Archives of pathology & laboratory medicine.
[23] S. Steinberg,et al. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. , 1990, Human pathology.
[24] A. L. Woods,et al. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects , 1990, Cell and tissue kinetics.
[25] S. Sheps,et al. Recent developments in the diagnosis and treatment of pheochromocytoma. , 1990, Mayo Clinic proceedings.
[26] R. Pontremoli,et al. Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma , 1989, Journal of endocrinological investigation.
[27] N. Samaan,et al. Diagnosis, localization, and management of pheochromocytoma pitfalls and follow‐up in 41 patients , 1988, Cancer.
[28] E. Gelmann,et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. , 1988, Annals of internal medicine.
[29] M. Miettinen,et al. Pheochromocytoma combined with malignant schwannoma: unusual neoplasm of the adrenal medulla. , 1988, Ultrastructural pathology.
[30] L. Rainwater,et al. Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. , 1986, Surgery.
[31] R. Lloyd,et al. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues. , 1985, Archives of pathology & laboratory medicine.
[32] L. Medeiros,et al. Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. , 1985, Human pathology.
[33] Scott Hw,et al. Oncologic aspects of pheochromocytoma: the importance of follow-up. , 1984 .
[34] W. Beierwaltes,et al. Radiopharmaceutical treatment of malignant pheochromocytoma. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] R. Lloyd,et al. MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION , 1984, Clinical endocrinology.
[36] H. Scott,et al. Oncologic aspects of pheochromocytoma: the importance of follow-up. , 1984, Surgery.
[37] J. Meyer,et al. Error and corrections with scintigraphic measurement of gastric emptying of solid foods. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] E. Wiener. Pheochromocytoma: Current status and changing trends , 1983 .
[39] J. Oates,et al. Clinical experience with malignant pheochromocytomas. , 1982, Surgery, gynecology & obstetrics.
[40] P. Sheedy,et al. Pheochromocytoma: current status and changing trends. , 1982, Surgery.
[41] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[42] S. Sheps,et al. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2 , 1980, The American journal of surgical pathology.
[43] J. Farndon,et al. Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results , 1979, The British journal of surgery.
[44] J. Groopman,et al. Sipple's syndrome with a malignant pheochromocytoma presenting as a pericardial effusion. , 1978, The Cardiology.
[45] M. Melicow. One hundred cases of pheochromocytoma (107 tumors) at the columbia‐presbyterian medical center, 1926‐1976. A clinicopathological analysis , 1977, Cancer.
[46] T. Nagatsu,et al. ADRENAL PHEOCHROMOCYTOMA WITH BOTH BENIGN AND MALIGNANT COMPONENTS , 1976, Acta pathologica japonica.
[47] S. Kay. Hyperplasia and neoplasia of the adrenal gland. , 1976, Pathology annual.
[48] J. Rohde. Letter: Push-pull factors and the doctor drain. , 1975, Lancet.
[49] P. D. Lewis. A cytophotometric study of benign and malignant phaeochromocytomas , 1971, Virchows Archiv. B, Cell pathology.
[50] R. Sherwin,et al. Histopathology of pheochromocytoma , 1959, Cancer.
[51] W. Peart,et al. Malignant phaeochromocytoma with functioning metastases. , 1955, Lancet.
[52] W. A. Bennett,et al. Pheochromocytoma; a study of 15 cases diagnosed at autopsy. , 1954, The New England journal of medicine.
[53] T. Symington,et al. Studies in phaeochromocytoma. I. Pathological aspects. , 1953 .
[54] T. Symington,et al. Studies in Phaeochromocytoma , 1953, Glasgow medical journal.
[55] E. S. King. Malignant phæochromocytoma of the adrenals , 1931 .